General Information of the Compound
| Compound ID |
CP0520598
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-bromo-4-N-(5-ethyl-1H-pyrazol-3-yl)-2-N-[(3-pyridin-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H17BrN8O
|
||||||||||||||||||
| Molecular Weight |
441.293
|
||||||||||||||||||
| Canonical SMILES |
CCc1cc(Nc2nc(NCc3cc(no3)-c3ccccn3)ncc2Br)[nH]n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H17BrN8O/c1-2-11-7-16(26-25-11)23-17-13(19)10-22-18(24-17)21-9-12-8-15(27-28-12)14-5-3-4-6-20-14/h3-8,10H,2,9H2,1H3,(H3,21,22,23,24,25,26)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OCTJJTONFVZCDV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01104, Insulin-like growth factor 1 receptor
Protein ID: PT00864, Vascular endothelial growth factor receptor 2